Mucormycosis, pseudallescheriasis, and other uncommon mold infections.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Proceedings of the American Thoracic Society

• Publication date

  2010-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1513/pats.200906-033ALPMID 20463250PMCID PMC3266012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent advances in the management of mucormycosis: from bench to bedside.

  2009cited by this paper
• Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi.

  2009cited by this paper
• Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for Mucormycosis

  2009cited by this paper
• A review of German Scedosporium prolificans cases from 1993 to 2007.

  2009cited by this paper
• Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases.

  2009cited by this paper
• Pseudallescheriasis: a summary of patients from 1980-2003 in a tertiary care center.

  2009cited by this paper
• Spectrum of Zygomycete Species Identified in Clinically Significant Specimens in the United States

  2009cited by this paper
• Combination Echinocandin-Polyene Treatment of Murine Mucormycosis

  2008cited by this paper
• Reversed halo sign in invasive pulmonary fungal infections.

  2008cited by this paper
• Posaconazole Mono- or Combination Therapy for Treatment of Murine Zygomycosis

  2008cited by this paper
• Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.

  2008cited by this paper
• Imaging of pulmonary fusariosis in patients with hematologic malignancies.

  2008cited by this paper
• Detection of a Molecular Biomarker for Zygomycetes by Quantitative PCR Assays of Plasma, Bronchoalveolar Lavage, and Lung Tissue in a Rabbit Model of Experimental Pulmonary Zygomycosis

  2008cited by this paper
• Posaconazole Combined with Amphotericin B, an Effective Therapy for a Murine Disseminated Infection Caused by Rhizopus oryzae

  2008cited by this paper
• Real-Time PCR Method for Detection of Zygomycetes

  2008cited by this paper
• Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis.

  2008cited by this paper
• Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

  2008cited by this paper
• Scedosporium apiospermum infection after near‐drowning

  2007cited by this paper
• Fusarium Infections in Immunocompromised Patients

  2007cited by this paper
• Imaging findings of pulmonary infection caused by Scedosporium prolificans in a deep immunocompromised patient’

  2007cited by this paper
• Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.

  2007cited by this paper
• The iron chelator deferasirox protects mice from mucormycosis through iron starvation.

  2007cited by this paper
• Comparative Analysis of Amphotericin B Lipid Complex and Liposomal Amphotericin B Kinetics of Lung Accumulation and Fungal Clearance in a Murine Model of Acute Invasive Pulmonary Aspergillosis

  2007cited by this paper
• Pharmacokinetics, Safety, and Efficacy of Posaconazole in Patients with Persistent Febrile Neutropenia or Refractory Invasive Fungal Infection

  2006cited by this paper
• Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases.

  2006cited by this paper
• Disseminated fusariosis presenting with pulmonary nodules following a line infection.

  2006cited by this paper
• Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.

  2006cited by this paper
• Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006.

  2006cited by this paper
• Compartmentalized Intrapulmonary Pharmacokinetics of Amphotericin B and Its Lipid Formulations

  2006cited by this paper
• Comparative Efficacies, Toxicities, and Tissue Concentrations of Amphotericin B Lipid Formulations in a Murine Pulmonary Aspergillosis Model

  2006cited by this paper
• Fusarium oxysporum Pneumonia in an Immunocompetent Host

  2006cited by this paper
• Posaconazole as Salvage Therapy for Zygomycosis

  2006cited by this paper
• Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management

  2005cited by this paper
• Combination Therapy with Amphotericin B Lipid Complex and Caspofungin Acetate of Disseminated Zygomycosis in Diabetic Ketoacidotic Mice

  2005cited by this paper
• Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer.

  2005cited by this paper
• Iron-chelating therapy with the new oral agent ICL670 (Exjade).

  2005cited by this paper
• Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.

  2005cited by this paper
• Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

  2005cited by this paper
• Caspofungin Inhibits Rhizopus oryzae 1,3-β-d-Glucan Synthase, Lowers Burden in Brain Measured by Quantitative PCR, and Improves Survival at a Low but Not a High Dose during Murine Disseminated Zygomycosis

  2005cited by this paper
• Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus

  2004cited by this paper
• Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.

  2004cited by this paper
• Improved Outcome of Zygomycosis in Patients with Hematological Diseases?

  2004cited by this paper
• Respiratory tract intracavitary colonization due to Scedosporium apiospermum: report of four cases.

  2004cited by this paper
• Zygomycosis: reemergence of an old pathogen.

  2004cited by this paper
• Scedosporium/Pseudallescheria infections.

  2004cited by this paper
• Fusarium infection in hematopoietic stem cell transplant recipients.

  2004cited by this paper
• Chronic Fusarium infection in an adult patient with undiagnosed chronic granulomatous disease.

  2003cited by this paper
• Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.

  2003cited by this paper
• Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

  2002cited by this paper
• The direct cost and incidence of systemic fungal infections.

  2002cited by this paper
• Cases from the Osler Medical Service at Johns Hopkins University. Scedosporium apiospermum mycetoma of the lung.

  2002cited by this paper
• In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes

  2002cited by this paper
• Cases from the Osler Medical Service at Johns Hopkins University.

  2002cited by this paper
• [Risk factor for invasive zygomycosis in patients with hematologic malignancies].

  2002cited by this paper
• Pseudallescheria boydii (Anamorph Scedosporium apiospermum) Infection in Solid Organ Transplant Recipients in a Tertiary Medical Center and Review of the Literature

  2002cited by this paper
• Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000

  2002cited by this paper
• Pseudallescheriasis of the lung and central nervous system: multimodality imaging.

  2001cited by this paper
• Pulmonary infection with Scedosporium prolificans in an immunocompetent individual.

  2001cited by this paper
• In Vitro Activities of Four Novel Triazoles againstScedosporium spp

  2001cited by this paper
• Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections.

  2001cited by this paper
• Fusarium infection after solid-organ transplantation.

  2001cited by this paper
• Zygomycetes in human disease.

  2000cited by this paper
• Zygomycosis in the 1990s in a tertiary-care cancer center.

  2000cited by this paper
• Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis

  1999cited by this paper
• Disseminated Pseudallescheria boydii infection in a nonimmunocompromised host.

  1999cited by this paper
• Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts

  1998cited by this paper
• Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease.

  1998cited by this paper
• Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management.

  1997cited by this paper
• Pulmonary mucormycosis: radiologic findings in 32 cases.

  1997cited by this paper
• In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds

  1997cited by this paper
• Isolated pulmonary mucormycosis in an apparently normal host: a case report.

  1995cited by this paper
• Pulmonary mucormycosis: results of medical and surgical therapy.

  1994cited by this paper
• Invasive pulmonary pseudallescheriasis with direct invasion of the thoracic spine in an immunocompetent patient

  1994cited by this paper
• Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

  1993cited by this paper
• The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection.

  1990cited by this paper
• The epidemiology of pseudallescheriasis complicating transplantation: Nosocomial and community‐acquired infection

  1990cited by this paper
• Murine model of pulmonary mucormycosis in cortisone-treated mice.

  1982cited by this paper
• A Mechanism of Susceptibility to Mucormycosis in Diabetic Ketoacidosis Transferrin and Iron Availability

  1982cited by this paper
• Non-commercial Research and Educational Use including without Limitation Use in Instruction at Your Institution, Sending It to Specific Colleagues That You Know, and Providing a Copy to Your Institution's Administrator. All Other Uses, Reproduction and Distribution, including without Limitation Comm

  year unknowncited by this paper

• Safety of Rhizomucor pusillus biomass powder as a novel food pursuant to Regulation (EU) 2015/2283

  2025cites this paper
• In silico and in vitro safety assessment of a fungal biomass from Rhizomucor pusillus for use as a novel food ingredient.

  2023cites this paper
• Case Report: Is Surgical Treatment Beneficial for Intracranial Basal Ganglia Cunninghamellamycosis Following Haematopoietic Stem Cell Transplantation?

  2022cites this paper
• The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance

  2022cites this paper
• COVID 19 associated Rhino- Orbital- Cerebral Mucormycosis: A proposed Classification and Treatment Strategies.

  2022cites this paper
• Rapidly progressive lung coinfection due to Rhizopus and Scedosporium in a diabetic marijuana smoker.

  2022cites this paper
• Safety Evaluation of Fermotein: Allergenicity, Mycotoxin Production, Biochemical Analyses and Microbiology of a Fungal Single-cell Protein Product

  2020cites this paper
• Immunomodulatory Properties of Antifungal Agents on Immune Functions of the Host

  2019cites this paper
• Pathogenicity patterns of mucormycosis: epidemiology, interaction with immune cells and virulence factors

  2019cites this paper
• What Is the Target? Clinical Mycology and Diagnostics

  2018cites this paper
• Fungi that Infect Humans

  2017cites this paper
• Cutaneous Pseaudallescheria Boydii Infection- Two Rare Case Reports

  2016cites this paper
• Food preparation with mucoralean fungi: A potential biosafety issue?

  2016cites this paper
• Cavitary Lung Disease in a Heart Transplant Patient

  2016influential citation
• Lung Transplantation for Cystic Fibrosis: Results, Indications, Complications, and Controversies

  2015cites this paper
• UvA-DARE ( Digital Academic Repository ) Mucorales between food and infection

  2014cites this paper
• Re-imagining the surveillance of invasive mould diseases

  2014cites this paper
• The spectrum of fungi that infects humans.

  2014cites this paper
• Diversity and delimitation of Rhizopus microsporus

  2013cites this paper
• In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.

  2013cites this paper
• Granulomatous Pododermatitis in the Digits Caused by Fusarium proliferatum in a Cat

  2013cites this paper
• 5 Pulmonary Infections

  2012cites this paper
• The appearance of pulmonary mucormycosis on FDG PET/CT.

  2012cites this paper
• The emerging epidemiology of mould infections in developing countries

  2011cites this paper
• Pulmonary Infections

  2011cites this paper